Baolan Li

1.7k total citations
16 papers, 78 citations indexed

About

Baolan Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Baolan Li has authored 16 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Baolan Li's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (6 papers). Baolan Li is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (6 papers). Baolan Li collaborates with scholars based in China and United States. Baolan Li's co-authors include Ying Hu, Ming‐Ming Hu, Jiabei He, Tongmei Zhang, Siyi Zhang, Dan Zhao, Hongmei Zhang, Yun Fan, Xinjie Yang and Xiaoli Zhu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Baolan Li

15 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baolan Li China 6 36 35 27 21 6 16 78
Anna Morra Italy 4 32 0.9× 18 0.5× 24 0.9× 22 1.0× 5 0.8× 10 90
Sara Benlloch United Kingdom 5 29 0.8× 62 1.8× 25 0.9× 24 1.1× 10 1.7× 6 115
Audrey Rabeau France 6 64 1.8× 36 1.0× 12 0.4× 18 0.9× 10 1.7× 16 96
Yikun Cheng China 7 29 0.8× 26 0.7× 30 1.1× 69 3.3× 15 2.5× 8 105
Hoi-Lam Ngan Hong Kong 3 41 1.1× 23 0.7× 21 0.8× 44 2.1× 7 1.2× 3 92
Yong Cheng China 5 32 0.9× 35 1.0× 39 1.4× 60 2.9× 6 1.0× 8 113
Hana Zahed France 5 41 1.1× 15 0.4× 25 0.9× 15 0.7× 4 0.7× 10 81
Penny Towne United States 5 69 1.9× 53 1.5× 28 1.0× 19 0.9× 3 0.5× 9 89
Benjie Shan China 7 32 0.9× 37 1.1× 33 1.2× 58 2.8× 11 1.8× 14 118

Countries citing papers authored by Baolan Li

Since Specialization
Citations

This map shows the geographic impact of Baolan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baolan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baolan Li more than expected).

Fields of papers citing papers by Baolan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baolan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baolan Li. The network helps show where Baolan Li may publish in the future.

Co-authorship network of co-authors of Baolan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Baolan Li. A scholar is included among the top collaborators of Baolan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baolan Li. Baolan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Li, Tong, Mingming Hu, Yajun Wang, et al.. (2024). Immuno-combined treatment versus radio-combined treatment in limited-stage small-cell lung cancer. Therapeutic Advances in Medical Oncology. 16. 12751927–12751927.
3.
4.
Liu, Yanxia, Yuan Gao, Ying Wang, et al.. (2022). A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice. BMC Cancer. 22(1). 1175–1175. 6 indexed citations
5.
6.
Hu, Mingming, Jinjing Tan, Lifeng Li, et al.. (2022). Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients. Frontiers in Oncology. 11. 806845–806845. 10 indexed citations
7.
Li, Baolan, Lin Wu, Zhijie Pan, et al.. (2022). Efficacy and safety of ASK120067 (limertinib) in patients with locally advanced or metastatic EGFR T790M-mutated non–small cell lung cancer: A multicenter, single-arm, phase IIb study.. Journal of Clinical Oncology. 40(16_suppl). 9106–9106. 3 indexed citations
8.
9.
Hu, Ying, et al.. (2020). [Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis].. SHILAP Revista de lepidopterología. 23(5). 337–342. 4 indexed citations
10.
11.
Hu, Mingming, Tongmei Zhang, Yuan Yang, et al.. (2020). Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases. The International Journal of Biological Markers. 35(4). 44–50. 1 indexed citations
12.
Zheng, Hua, Yuan Gao, Zhe Qian, et al.. (2019). Investigation of therapeutic modalities of G719X, an uncommon mutation in the EGFR gene in non-small cell lung cancer. Oncology and Translational Medicine. 5(2). 91–97. 1 indexed citations
13.
He, Jiabei, Ying Hu, Ming‐Ming Hu, Siyi Zhang, & Baolan Li. (2016). The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer. Scientific Reports. 6(1). 20586–20586. 20 indexed citations
14.
Wang, Qunhui, Hua Zheng, Hongmei Zhang, et al.. (2016). [Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations].. SHILAP Revista de lepidopterología. 19(8). 550–8. 5 indexed citations
15.
Zheng, Hua, et al.. (2014). Favorable response to icotinib in a lung cancer patient with a special mutation at exon 19 of epidermal growth factor receptor. Thoracic Cancer. 5(4). 358–361. 5 indexed citations
16.
Zhang, Tongmei, Na Qin, & Baolan Li. (2010). [Well-differentiated fetal adenocarcinoma of lung: a case report with 14 cases literature review].. PubMed. 13(8). 838–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Morra Breakdown of academic impact, for papers by Sara Benlloch Breakdown of academic impact, for papers by Audrey Rabeau Breakdown of academic impact, for papers by Yikun Cheng Breakdown of academic impact, for papers by Hoi-Lam Ngan Breakdown of academic impact, for papers by Yong Cheng Breakdown of academic impact, for papers by Hana Zahed Breakdown of academic impact, for papers by Penny Towne Breakdown of academic impact, for papers by Benjie Shan
Rankless by CCL
2026